GWAG
LGND icon

Garrett Wealth Advisory Group’s Ligand Pharmaceuticals LGND Stock Holding History

Garrett Wealth Advisory Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21
Closed -$1.29K – 380
2019
Q3 		$1.29K Buy
+21
New +$1.32K ﹤0.01% 665

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Garrett Wealth Advisory Group's LGND Position: Q4 2019 in Review

Garrett Wealth Advisory Group sold out of Ligand Pharmaceuticals (LGND) in Q4 2019, closing a stake of 21 shares — an estimated $1.29K sold.

Garrett Wealth Advisory Group first reported a position in LGND in Q3 2019 and held it in 1 quarter. The position peaked at $1.29K in Q3 2019. 266 funds tracked by Wall St. Rank hold LGND as of Q4 2019.

  • Garrett Wealth Advisory Group reported no remaining Ligand Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Garrett Wealth Advisory Group sold 21 Ligand Pharmaceuticals shares in Q4 2019, an estimated $1.29K.
  • Garrett Wealth Advisory Group first reported a position in Ligand Pharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Garrett Wealth Advisory Group's Ligand Pharmaceuticals position peaked at $1.29K in Q3 2019.
  • 266 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2019.

Based on Garrett Wealth Advisory Group's 13F filing for Q4 2019, filed 28 Jan 2020.